| Report ID | 283258 |
| Drug Identification Number | 02256290 |
| Brand name | RELPAX |
| Common or Proper name | ELETRIPTAN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ELETRIPTAN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1x6 BLS |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-05-22 |
| Actual start date | |
| Estimated end date | 2026-08-25 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-04-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-20 | French | Compare |
| v1 | 2026-04-20 | English | Compare |
Showing 1 to 2 of 2